Name | Futura Medical |
---|---|
Epic | FUM |
Isin | GB0033278473 |
Index | AIM100 AIM350 |
Industry | Pharmaceuticals & Biotechnology |
Latest share price | 33.30p | Net gearing | n/a |
---|---|---|---|
Market capitalisation | £101.13 | Debt ratio | n/a |
Shares in issue | 301.45 | Debt-to-equity ratio | n/a |
P/E ratio | n/a | Assets / equity ratio | n/a |
Total dividends per share | n/a | Price to book value | n/a |
Dividend yield | n/a | ROCE | -127.15 |
Dividend cover | n/a | EPS growth | n/a |
Earning per share | -2.21 | 52-week high / low | 25.50p / 45.55p |
Type | Ex-date | Pay-date | Net-dividend |
---|---|---|---|
No dividends declared |
Company name | Futura Medical |
---|---|
Address | Surrey Technology Centre, 40 Occam Road, Guildford, Surrey, United Kingdom, GU2 7YG |
Telephone | +44 (0) 1483 685670 |
Website | http://www.futuramedical.com/ |
Director | Position |
---|---|
Mr James Henry Barder | CEO |
Mr Angela Hildreth | Finance Director |
Mr Roy Davis | Non-Executive Director |
Mr Ken James | Executive Director |
Mr Jeff Needham | Non-Executive Chairman |
Mr Andrew Vaughan Unitt | Senior Independent Non-Executive Director |
Assets £ (m) | 2023 | 2022 | 2021 |
---|---|---|---|
Reporting date | 31/12/23 | 31/12/22 | 31/12/21 |
Intangible asssets and goodwill | n/a | n/a | n/a |
Investments and other non-current assets | n/a | n/a | n/a |
Total non-current assets | 2.48 | 1.16 | 0.44 |
Inventory / work in progress | n/a | n/a | n/a |
Trade and other receivables | 1.24 | 0.27 | 0.08 |
Cash and equivalents | 7.71 | 4.03 | 10.37 |
Other current assets and asset held for resale | 0.38 | 1.02 | 0.91 |
Total of all assets | 11.82 | 6.47 | 11.8 |
Liabilities £ (m) | 2023 | 2022 | 2021 |
---|---|---|---|
Short term liabilities | 6.34 | -1.75 | 2.08 |
Long term liabilities | n/a | n/a | n/a |
Other liabilites / pension etc | n/a | n/a | n/a |
Total of all liabilities | 6.34 | -1.75 | 2.08 |
Net assets £ (m) | 2023 | 2022 | 2021 |
---|---|---|---|
Net assets | 5.48 | 8.23 | 9.72 |
Equity £ (m) | 2023 | 2022 | 2021 |
---|---|---|---|
Share capital | 0.6 | 0.58 | 0.57 |
Minority interests | n/a | n/a | n/a |
Retained earnings | -67.35 | -63.72 | -58.55 |
Share premium account | 71.07 | 66.55 | 66.38 |
Total equity | 5.48 | 8.23 | 9.72 |
Income £ (m) | 2023 | 2022 | 2021 |
---|---|---|---|
Turnover | n/a | n/a | n/a |
Operating profit | -6.96 | -6.87 | -5.87 |
Pre-tax profit | -6.89 | -6.87 | -5.87 |